Package 68462-293-05

{"route": ["ORAL"], "spl_id": "c4ac347e-78cd-490d-9047-73a1df2bd717", "openfda": {"upc": ["0368462292013", "0368462293010", "0368462260012"], "unii": ["V3888OEY5R"], "rxcui": ["897640", "897649", "897659"], "spl_set_id": ["ba1bf1ae-9347-4d17-998b-14bf7b5984ce"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-293-01)", "package_ndc": "68462-293-01", "marketing_start_date": "20110805"}, {"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-293-05)", "package_ndc": "68462-293-05", "marketing_start_date": "20110805"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-293-90)", "package_ndc": "68462-293-90", "marketing_start_date": "20110805"}], "brand_name": "verapamil hydrochloride", "product_id": "68462-293_c4ac347e-78cd-490d-9047-73a1df2bd717", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "68462-293", "generic_name": "verapamil hydrochloride", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "verapamil hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "180 mg/1"}], "application_number": "ANDA090700", "marketing_category": "ANDA", "marketing_start_date": "20110805", "listing_expiration_date": "20261231"}